Assessing Abbott Laboratories (ABT) Valuation After Libre Assist Expands Its Digital Diabetes Offering [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
See our latest analysis for Abbott Laboratories. The Libre Assist launch comes as Abbott's 1 month share price return sits at 4.07% and its year to date share price return is 1.60%, while the 1 year total shareholder return of 12.53% points to steady momentum rather than a sharp re rating. If Libre Assist has you rethinking digital health opportunities, it could be a good moment to scan other healthcare stocks that are trying to reshape how care is delivered. With shares up 4.07% over the past month and trading at $126.18, while sitting at a 14.75% discount to the average analyst target, is Abbott quietly offering an entry point, or is the market already baking in Libre driven growth? With Abbott Laboratories last closing at $126.18 versus a narrative fair value of about $144.43, the valuation hinges on how durable its earnings power really is. The analysts have a consensus price target of $142.485 for Abbott Laboratories based on their expectations of its future earnings g
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Innovative Health Receives 50th FDA Clearance to Reprocess Medical Devices [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE:ABT) is favoured by institutional owners who hold 80% of the company [Yahoo! Finance]Yahoo! Finance
- Can your toothbrush really detect diabetes? FDA scrutiny grows for health-tracking gadgets [Los Angeles Times (CA)]Los Angeles Times
- Global Pain Management Devices Market to Reach USD 5,835.8 Million by 2029 | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE:ABT) had its price target raised by analysts at Sanford C. Bernstein from $150.00 to $154.00. They now have an "outperform" rating on the stock.MarketBeat
ABT
Earnings
- 10/15/25 - In-Line
ABT
Sec Filings
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- ABT's page on the SEC website